celgene patient support logo
celgene patient support logo

A single source
for access support

A single source for access support

Celgene Patient Support® provides:
Celgene Patient Support® provides:
  • A single Celgene Patient Support® Specialist assigned to help patients in your geographic area
  • Assistance with understanding patient insurance coverage for ABRAXANE
  • Information about financial assistance for ABRAXANE
orange line
orange line

Financial Assistance*

Depending on the patient's insurance situation, there are programs and organizations that may help pay for ABRAXANE

  • Celgene Commercial Co-pay Program for eligible patients with commercial or private insurance (including healthcare exchanges)*
  • Independent third-party organizations for patients who are unable to afford their medication (including patients with Medicare, Medicaid, or other government-sponsored insurance)
  • Celgene Patient Assistance Program (PAP) for qualified patients who are uninsured or underinsured
Insurance-related assistance

On behalf of the patient, our Specialists are available to assist with each of the following steps in the insurance approval process for ABRAXANE§

  • Initiating a benefits investigation
  • Assessing pre-certification requirements
  • Providing information about the appeals process
  • Educating patients about insurance coverage or other programs for which they may qualify

  • *Other eligibility requirements and restrictions apply. Please see full Terms and Conditions.
  • *Other eligibility requirements and restrictions apply. Please see
    full Terms and Conditions.
  • Financial and medical eligibility requirements vary by organization.
  • Patients must meet specified financial and eligibility requirements to qualify for assistance.
  • §Celgene cannot provide insurance advice or make insurance decisions.

There are 3 simple ways to enroll in Celgene Patient Support®
celgene patient support enroll
Enroll online at celgenepatientsupport.com
Call us at 1-800-931-8691, Monday – Thursday,
8 AM – 7 PM ET, and Friday, 8 AM – 6 PM ET
or fax 1-800-822-2496
(translation services available)
YOU ARE NOW LEAVING www.abraxanepro.com
Additional Information for Readers Provided by Celgene Corporation

The clinical trial described in this article served as the
basis for the approval for ABRXANE for Injectable Suspension.
The analyses contained in the article may differ from those in the package insert for ABRAXANE.

Please see Important Safety Information and Prescribing Information, including Boxed WARNING.

Click “OK” to proceed or “CANCEL” to return to
www.abraxanepro.com

OK
CANCEL